Company / R&D Expense
Medline Inc. R&D Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$80.0M
FY2025
5-year range
$60.0M / $80.0M
FY2023-FY2025
Trend
+19.4%
vs FY2024
Sector context
#66 of 110
Health Care
What the data says
At $80M, Medline Inc.'s r&d expense ranks #66 of 110 in the Health Care sector. Improved from $60M to $80M over the past 2 years.
Based on SEC 10-K filings.
$80M in FY2025.
Improved from $60M to $80M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#66 of 110 in Health CareTop 60% of 110This company $80.0M Sector average $298.2M
▼
-73.2% below sector average
Key checks
Key Insights
- In FY2025, r&d expense increased 19.4% year-over-year.
- Ranks #66 out of 110 companies in the Health Care sector.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $80.0M | +19.4% |
| FY2024 | $67.0M | +11.7% |
| FY2023 | $60.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026